Effects of intrarenal infusion of 17-octadecynoic acid on renal antihypertensive mechanisms in anesthetized rabbits

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 803-812

  Evans, Roger G ^a   Day, Katrina H ^b   Roman, Richard J ^b   Hopp, Kathy H ^b   Anderson, Warwick P ^b  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Arachidonic acid; Cytochrome P450; Medullipin; Pressure natriuresis; Renal perfusion pressure

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; FATTY ACID; MEDULLIPIN 1; MEDULLIPIN 2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HYPERTENSION; KIDNEY MICROSOME; KIDNEY PERFUSION; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANESTHESIA; ANGIOTENSIN I; ANIMALS; ARACHIDONIC ACID; BLOOD PRESSURE; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS, UNSATURATED; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; KIDNEY; MALE; PERFUSION; PRESSURE; RABBITS; RENAL CIRCULATION; RENIN; SODIUM;

EID: 0032127014     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00045-4     Document Type: Article

References (46)

1. 1. Roman RJ, Zou A-P: Influence of the renal medullary circulation on the control of sodium excretion. Am J Physiol 1993;265:R963-R973.
2. 2. Anderson WP, Evans RG, Malpas SC: Pressure natriuresis and long-term blood pressure control. J Cardiovasc Pharmacol 1995;26(suppl 2):S17-S23.
3. 3. Muirhead EE: Medullipin system of blood pressure control. News Physiol Sci 1990;5:241-244.
4. 4. Thomas CJ, Woods RL, Evans RG, et al: Evidence for a renomedullary vasodepressor hormone. Clin Exp Pharmacol Physiol 1996;23:777-785.
5. 5. Cowley AW Jr: Long-term control of arterial blood pressure. Physiol Rev 1992;72:231-300.
6. 6. Cowley AW Jr: Evolution of the medullipin concept of blood pressure control: a tribute to Eric Muirhead. J Hypertens 1994;12(suppl 10):S25-S34.
7. 7. Muirhead EE, Byers LW, Brooks B, et al: Hepatic enzyme induction by phenobarbital potentiates the anti-hypertensive function of the kidney. J Hypertens 1986; 4(suppl 6):S623-S625.
8. 8. Muirhead EE, Byers LW, Capdevila J, et al: The renal antihypertensive endocrine function: its relation to cytochrome P-450. J Hypertens 1989;7:361-369.
9. 9. Fitzpatrick FA, Murphey RC: Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxgenase"-derived eicosanoids. Pharmacol Rev 1989;40:229-241.
10. 10. Zou A-P, Ma Y-H, Sui Z-H, et al: Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 1994;268:474-481.
11. 11. Zou A-P, Muirhead EE, Cowley AW, et al: Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension. J Hypertens 1995;13:557-566.
12. 12. Muirhead EE, Brooks B, Byers LW: Secretion of medullipin I by the kidney involves the cytochrome P-450 enzyme system. J Hypertens 1994;12:155-158.
13. 13. Muirhead EE, Brooks B, Byers LW, et al: Secretion of medullipin I by isolated kidneys perfused under elevated pressure. Clin Exp Pharmacol Physiol 1991;18: 409-417.
14. 14. Gothberg G: Physiology of the renomedullary depressor system. J Hypertens 1994;12(suppl 10):S57-S64.
15. 15. Gebremedhin D, Ma Y-H, Imig JD, et al: Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. J Vasc Res 1993;30:53-60.
16. 16. Oyekan AO: Role of the cytochrome P450 enzyme system as a humoral modulator of vasomotor responses in rat renal vasculature. J Cardiovasc Pharmacol 1994;24: 238-246.
17. 17. Vazquez B, Rios A, Escalante B: Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci 1995;56:1455-1466.
18. 18. Kauser K, Clark JE, Masters BS, et al: Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res 1991;68:1154-1163.
19. 19. Imig JD, Zou A-P, Ortiz de Montellano PR, et al: Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am J Physiol 1994; 266:H1879-H1885.
20. 20. Ma Y-H, Gebremedhin D, Schwartzman ML, et al: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993;72:126-136.
21. 21. Ma Y-H, Harder DR, Clark JE, Roman RJ: Effects of 12-HETE on isolated dog renal arcuate arteries. Am J Physiol 1991;261:H451-H456.
22. 22. Oyekan AO, McGiff JC, Quilley J: Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat. Circ Res 1991; 68:958-965.
23. 23. Escalante B, Erlij D, Falck JR, McGiff JC: Effects of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 1991; 251:799-802.
24. 24. Zou A-I, Imig JD, Ortiz de Montellano PR, et al: Effects of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol 1994;266: F934-F941.
25. 25. Takahashi K, Harris RC, Capdevila JH, et al: Induction of renal arachidonate cytochrome P-450 epoxygenase after uninephrectomy: counterregulation of hyperfiltration. J Am Soc Nephrol 1993;3:1496-1500.
26. 26. Zou A-P, Drummond HA, Roman RJ: Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension 1996;27:631-635.
27. 27. Takahashi K, Capdevila J, Karara A, et al: Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am J Physiol 1990;258:F781-F789.
28. 28. Omata K, Abraham NG, Schwartzman ML: Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am J Physiol 1992;262:F591-F599.
29. 29. Ma Y-H, Schwartzman ML, Roman RJ: Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol 1994;267:R579-R589.
30. 30. Schwartzman ML, da Silva JL, Lin F, et al: Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 1996;73:652-663.
31. 31. Makita K, Falck JR, Capdevila JH: Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. FASEB J 1996;10: 1456-1463.
32. 32. Stec DE, Trolliet MR, Krieger JE, et al: Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. Hypertension 1996;27:1329-1336.
33. 33. Christy IJ, Woods RL, Courneya CA, et al: Evidence for a renomedullary vasodepressor system in rabbits and dogs. Hypertension 1991;18:325-333.
34. 34. Christy IJ, Woods RL, Anderson WP: Mediators of the hypotensive response to increased renal perfusion in rabbits. Hypertension 1993;21:149-154.
35. 35. Thomas CJ, Woods RL, Gao Y, Anderson WP: Pressure range for release of renomedullary depressor substance in rabbits. Hypertension 1994;23:639-645.
36. 36. Thomas CJ, Anderson WP, Woods RL: Nitric oxide inhibition does not prevent the hypotensive response to increased renal perfusion in rabbits. Clin Exp Pharmacol Physiol 1995;22:345-351.
37. G-nitro-L-arginine on pressure natriuresis in anaesthetized rabbits. Clin Exp Pharmacol Physiol 1995;22:94-101.
38. 38. Muerhoff AS, Williams DE, Reich NO, et al: Prostaglandin and fatty acid ω-and (ω-1)-oxidation in rabbit lung. J Biol Chem 1989;264:749-756.
39. 39. Australian Code of Practice for the Care and Use of Animals for Scientific Purposes: Australian Government Publishing Service, Canberra, 1990.
40. 40. Oliver JR, Korner PI, Woods RL, Zhu JL: Reflex release of vasopressin and renin in hemorrhage is enhanced by autonomic blockade. Am J Physiol 1990;258:H221-H228.
41. 41. Wilkinson L: SYSTAT: The System for Statistics. Evanston, IL, SYSTAT Inc, 1990.
42. 42. Ludbrook J: Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994;28:303-311.
43. 43. Karlstrom G, Bergstrom G, Folkow B, et al: Is the humoral renal antihypertensive activity of the spontaneously hypertensive rat (SHR) reset to the high blood pressure? Acta Physiol Scand 1991;141:517-530.
44. 44. Harder DR, Campbell WB, Roman RJ: Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 1995;32: 79-92.
45. 45. Pitha J, Irie T, Sklar PB, Nye JS: Drug solubilisers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci 1988;43:493-502.
46. 46. VanRollins M, Kaduce TL, Fang X, et al: Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J Biol Chem 1996;271:14001-14009.